Quarterly Result11 May 2026, 08:31 pm
JB Chemicals: Audited FY26 Standalone & Consolidated Results
AI Summary
JB Chemicals & Pharmaceuticals Ltd. has announced its audited standalone and consolidated financial results for the year ended March 31, 2026. The results, along with the auditor's report by Deloitte Haskins & Sells LLP, were approved by the Board of Directors in a meeting held on the same day. The board also declared an unmodified opinion on the audited financial results. The company stated that disclosures regarding deviation/variation in public issue proceeds and outstanding loan defaults are not applicable for the quarter ended March 31, 2026.
Key Highlights
- Audited standalone and consolidated financial results for FY26 approved.
- Deloitte Haskins & Sells LLP issued the auditor's report.
- Unmodified opinion declared on FY26 audited financial results.
- Related Party Transactions for the half year ended March 31, 2026, were reviewed.
- Statement on Deviation/Variation and default disclosures not applicable for the quarter.
Price Impact
More from JBCHEPHARM